Biggest News Aggregation in the World
📰 Diffuse Largeb Cell News

Page 4 - Diffuse Largeb Cell News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Diffuse Largeb Cell. Real-time updates on events, politics, business and more.

AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual Meeting Evaluating Epcoritamab (DuoBody®-CD3xCD20) Across B-Cell Lymphomas

Four oral presentations presented at ASH highlight data evaluating investigational epcoritamab for the treatment of relapsed/refractory (R/R) foll...
United States Mohamed Zaki Genmab Duobody Data From The Observational National Lymphocare Study American Society Of Hematology Lymphoma Research Foundation

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in

COPENHAGEN, Denmark--(BUSINESS WIRE)--Epcoritamab featured in multiple data disclosures, including four oral presentationsResults presented from the phase 1b/2 EPCORE™ NHL-2 trial of epcoritamab combined with standard salvage therapy in patients with transplant eligible relapsed/refractory (R/R) diffuse large B-cell...
United States New Orleans New Jersey David Freundel Judith Klimovsky Exposition Of The American Society Hematology

Genmab A/S: Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody-CD3xCD20) in Patients Across a Broad Range of B-Cell Lymphomas at the 64th Annual ASH Meeting

Epcoritamab featured in multiple data disclosures, including four oral presentations Results presented from the phase 1b/2 EPCORE NHL-2 trial of epcoritamab combined with standard salvage
United States New Orleans New Jersey David Freundel Judith Klimovsky Andrew Carlsen

AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual Meeting Evaluating Epcoritamab (DuoBody®-CD3xCD20) Across B-Cell Lymphomas

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced data from multiple clinical trials evaluating epcoritamab (DuoBody®-CD3xCD20), an investigational...
United States Mohamed Zaki Genmab Duobody Data From The Observational National Lymphocare Study American Society Of Hematology Lymphoma Research Foundation

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science